Great news. Along with the recent announcement on the 7 million payment for Bronchitol things are looking good.
"The Company updated that US$7m of the milestone will be payable by Chiesi upon US approval of Bronchitol by the Food and Drug Administration (FDA) who have advised a Goal Action Date of 1 November 2020"
Ann: FDA Gives Green Light to Start Myelofibrosis Phase 2 Study, page-3
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
-0.002(6.45%) |
Mkt cap ! $32.23M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.0¢ | 2.7¢ | $189.4K | 6.695M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1320500 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 41696 | 4 |
View Market Depth
| Last trade - 11.48am 06/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |